Gb Sciences Completes $8 Million Sale of Las Vegas Cannabis Facility

Author's Avatar
Jan 11, 2022

The sale will accelerate the development of Gb Sciences' proprietary Parkinson's disease and COVID-related Cytokine-Release Syndrome therapies